108 related articles for article (PubMed ID: 12050207)
1. Long-term progestin treatment inhibits RANTES (regulated on activation, normal T cell expressed and secreted) gene expression in human endometrial stromal cells.
Zhao D; Lebovic DI; Taylor RN
J Clin Endocrinol Metab; 2002 Jun; 87(6):2514-9. PubMed ID: 12050207
[TBL] [Abstract][Full Text] [Related]
2. Sulindac suppresses nuclear factor-kappaB activation and RANTES gene and protein expression in endometrial stromal cells from women with endometriosis.
Wieser F; Vigne JL; Ryan I; Hornung D; Djalali S; Taylor RN
J Clin Endocrinol Metab; 2005 Dec; 90(12):6441-7. PubMed ID: 16159934
[TBL] [Abstract][Full Text] [Related]
3. IL-1beta induction of RANTES (regulated upon activation, normal T cell expressed and secreted) chemokine gene expression in endometriotic stromal cells depends on a nuclear factor-kappaB site in the proximal promoter.
Lebovic DI; Chao VA; Martini JF; Taylor RN
J Clin Endocrinol Metab; 2001 Oct; 86(10):4759-64. PubMed ID: 11600537
[TBL] [Abstract][Full Text] [Related]
4. Peritoneal macrophages induce RANTES (regulated on activation, normal T cell expressed and secreted) chemokine gene transcription in endometrial stromal cells.
Lebovic DI; Chao VA; Taylor RN
J Clin Endocrinol Metab; 2004 Mar; 89(3):1397-401. PubMed ID: 15001640
[TBL] [Abstract][Full Text] [Related]
5. Dioxin stimulates RANTES expression in an in-vitro model of endometriosis.
Zhao D; Pritts EA; Chao VA; Savouret JF; Taylor RN
Mol Hum Reprod; 2002 Sep; 8(9):849-54. PubMed ID: 12200463
[TBL] [Abstract][Full Text] [Related]
6. Regulation of aromatase P450 expression in endometriotic and endometrial stromal cells by CCAAT/enhancer binding proteins (C/EBPs): decreased C/EBPbeta in endometriosis is associated with overexpression of aromatase.
Yang S; Fang Z; Suzuki T; Sasano H; Zhou J; Gurates B; Tamura M; Ferrer K; Bulun S
J Clin Endocrinol Metab; 2002 May; 87(5):2336-45. PubMed ID: 11994385
[TBL] [Abstract][Full Text] [Related]
7. PPAR-gamma decreases endometrial stromal cell transcription and translation of RANTES in vitro.
Pritts EA; Zhao D; Ricke E; Waite L; Taylor RN
J Clin Endocrinol Metab; 2002 Apr; 87(4):1841-4. PubMed ID: 11932328
[TBL] [Abstract][Full Text] [Related]
8. Regulation of plasminogen activator inhibitor 1 expression by interaction of epidermal growth factor with progestin during decidualization of human endometrial stromal cells.
Lockwood CJ
Am J Obstet Gynecol; 2001 Apr; 184(5):798-804; discussion 804-5. PubMed ID: 11303186
[TBL] [Abstract][Full Text] [Related]
9. Transcriptional regulation of the tissue factor gene by progestins in human endometrial stromal cells.
Krikun G; Schatz F; Mackman N; Guller S; Lockwood CJ
J Clin Endocrinol Metab; 1998 Mar; 83(3):926-30. PubMed ID: 9506750
[TBL] [Abstract][Full Text] [Related]
10. Stromal PRs mediate induction of 17beta-hydroxysteroid dehydrogenase type 2 expression in human endometrial epithelium: a paracrine mechanism for inactivation of E2.
Yang S; Fang Z; Gurates B; Tamura M; Miller J; Ferrer K; Bulun SE
Mol Endocrinol; 2001 Dec; 15(12):2093-105. PubMed ID: 11731611
[TBL] [Abstract][Full Text] [Related]
11. NF-kappaB decoy oligonucleotides suppress RANTES expression and monocyte chemotactic activity via NF-kappaB inactivation in stromal cells of ectopic endometrium.
Xiu-li W; Su-ping H; Hui-hua D; Zhi-xue Y; Shi-long F; Pin-hong L
J Clin Immunol; 2009 May; 29(3):387-95. PubMed ID: 19172384
[TBL] [Abstract][Full Text] [Related]
12. Regulation of tissue factor gene expression in human endometrium by transcription factors Sp1 and Sp3.
Krikun G; Schatz F; Mackman N; Guller S; Demopoulos R; Lockwood CJ
Mol Endocrinol; 2000 Mar; 14(3):393-400. PubMed ID: 10707957
[TBL] [Abstract][Full Text] [Related]
13. [Influence of nuclear factor-kappaB decoy oligonucleotides on RANTES expression and monocyte chemotactic activity in stromal cells of ectopic endometrium].
Wang XL; Han SP; Fang CL; Mao YD; Wang W; Lu J; Zhang HM
Zhonghua Fu Chan Ke Za Zhi; 2008 Jul; 43(7):518-22. PubMed ID: 19080516
[TBL] [Abstract][Full Text] [Related]
14. Biological mechanisms underlying the clinical effects of RU 486: modulation of cultured endometrial stromal cell stromelysin-1 and prolactin expression.
Schatz F; Papp C; Aigner S; Krikun G; Hausknecht V; Lockwood CJ
J Clin Endocrinol Metab; 1997 Jan; 82(1):188-93. PubMed ID: 8989257
[TBL] [Abstract][Full Text] [Related]
15. [Effects of progesterone and progestin on expression of regulated on activation, normal T cell expressed and secreted in eutopic endometrium from patients with endometriosis].
Deng S; Dai Y; Lang JH; Leng JH; Liu ZF; Sun DW; Zhu L; Tan XJ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2007 Apr; 29(2):257-61. PubMed ID: 17536280
[TBL] [Abstract][Full Text] [Related]
16. Progesterone receptor regulates decidual prolactin expression in differentiating human endometrial stromal cells.
Brosens JJ; Hayashi N; White JO
Endocrinology; 1999 Oct; 140(10):4809-20. PubMed ID: 10499541
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor-beta inhibits progesterone-induced enkephalinase expression in human endometrial stromal cells.
Casey ML; MacDonald PC
J Clin Endocrinol Metab; 1996 Nov; 81(11):4022-7. PubMed ID: 8923854
[TBL] [Abstract][Full Text] [Related]
18. Stimulation of aromatase P450 promoter (II) activity in endometriosis and its inhibition in endometrium are regulated by competitive binding of steroidogenic factor-1 and chicken ovalbumin upstream promoter transcription factor to the same cis-acting element.
Zeitoun K; Takayama K; Michael MD; Bulun SE
Mol Endocrinol; 1999 Feb; 13(2):239-53. PubMed ID: 9973254
[TBL] [Abstract][Full Text] [Related]
19. Ligand-activated progesterone receptor isoform hPR-A is a stronger transactivator than hPR-B for the expression of IGFBP-1 (insulin-like growth factor binding protein-1) in human endometrial stromal cells.
Gao J; Mazella J; Tang M; Tseng L
Mol Endocrinol; 2000 Dec; 14(12):1954-61. PubMed ID: 11117526
[TBL] [Abstract][Full Text] [Related]
20. Biological mechanisms underlying RU 486 clinical effects: inhibition of endometrial stromal cell tissue factor content.
Lockwood CJ; Krikun G; Papp C; Aigner S; Nemerson Y; Schatz F
J Clin Endocrinol Metab; 1994 Sep; 79(3):786-90. PubMed ID: 8077362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
